Venture

Venture

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, confirming its commitment to advancing healthcare and life sciences.

Linx has built an AI-native platform that maps, monitors, and governs human, non-human, and agentic identities across the entire enterprise environment, relying on real-time detection and automated remediation to reduce identity-related risks.

Incyte tops this list due to its rare combination of commercial scale, cash generation, and pipeline depth. The company posted FY2025 revenue of $5.14 billion, up 21.2% YoY, anchored by Jakafi generating $828.2 million in Q4 2025 alone (+7% YoY) and Opzelura delivering $207.3 million (+28% YoY). With $3.58 billion in cash and 14 pivotal clinical trials underway, Incyte offers an acquirer immediate revenue, margin expansion potential, and a deep oncology pipeline spanning KRASG12D, CDK2 inhibition, and mutCALR.

Kato officially assumes her greatest challenge yet - CIO of Toyota's Woven Capital and CEO of Toyota Invention Partners. The latter appointment makes her the first female CEO of a wholly owned Toyota subsidiary.

Nicolas Sauvage, president of TDK Ventures, will explain the unique operations of corporate VCs and what founders should know about attracting investment.

Empirical Ventures has secured a £10 million commitment from the British Business Bank through its Regional Angels Programme, bringing the Bank's total support for the firm to £15 million. This funding will allow Empirical to write larger cheques to early-stage science-led founders across the UK, particularly outside London.

The funding arrives as Whoop hits some major business milestones, by Ahmed's telling. The company exited last year at a $1.1 billion bookings run rate, up 103% year over year.